Indeed, it has been reported that KDM4A plays an important role in the tumorigenesis and progression of NPC, thus indicating KDM4A as a promising biomarker and target for the treatment of NPC8. The gene discussed is KDM4A; the disease is nasopharyngeal carcinoma.